Related content

Transdermal Delivery of Treatment for Alzheimer's Disease: Development, Clinical Performance and Future Prospects

By Chan Agnes L.F.   Chien Yie W.   Shun Jin Lin  

Drugs & Aging, Vol. 25, Iss. 9, 2008-01 ,pp. : 761-775

Adis International

Access to resources Recommend Favorite

Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy

By Stoof J.C.   Winogrodzka A.   van Muiswinkel F.L.   Wolters E.C.   Voorn P.   Groenewegen H.J.   Booij J.   Drukarch B.  

European Journal of Pharmacology, Vol. 375, Iss. 1, 1999-06 ,pp. : 75-86

Elsevier

Access to resources Recommend Favorite

The Use of Clinical Trial Simulation to Support Dose Selection: Application to Development of a New Treatment for Chronic Neuropathic Pain

By Lockwood Peter A.   Cook Jack A.   Ewy Wayne E.   Mandema Jaap W.  

Pharmaceutical Research, Vol. 20, Iss. 11, 2003-11 ,pp. : 1752-1759

Springer Publishing Company

Access to resources Recommend Favorite

Noninvasive Brain Imaging for Experimental Medicine in Drug Discovery and Development: Promise and Pitfalls

By Whitcher Brandon   Matthews Paul M.  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 3, 2006-01 ,pp. : 167-175

Adis International

Access to resources Recommend Favorite

Does Non-Invasive Brain Stimulation Improve Cognition in Major Depressive Disorder? A Systematic Review

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 10, 2014-12 ,pp. : 1759-1769

Bentham Science Publishers

Access to resources Recommend Favorite